Italfarmaco S.p.A. today announced a comprehensive update on the regulatory and clinical advancements for givinostat, the ...
After winning a Study U.K. Alumni Award, columnist Shalom Lim looks back on the ups and downs of his life with Duchenne ...
ITF Therapeutics LLC, the U.S. affiliate of Italfarmaco, today announced the opening of the company's new U.S. headquarters in Concord, Massachusetts. The 10,000-square-foot facility located at 575 ...
PepGen has previously faced an FDA clinical hold on the investigational new drug application of PGN-ENO51 in the Phase II ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback